Loading clinical trials...
Loading clinical trials...
An Open Multi-center Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCTB39-1 in Adult Patients With Advanced Malignant Solid Tumours
Conditions
Interventions
SCTB39-1
Locations
1
China
Cancer Hospital Chinese Academy of Medical Science
Beijing, China
Start Date
June 23, 2025
Primary Completion Date
June 30, 2028
Completion Date
June 30, 2028
Last Updated
July 4, 2025
NCT06658951
NCT07293754
NCT06717750
NCT06380309
NCT07292402
NCT07045454
Lead Sponsor
Sinocelltech Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions